A detailed history of Cva Family Office, LLC transactions in Haleon PLC stock. As of the latest transaction made, Cva Family Office, LLC holds 125 shares of HLN stock, worth $1,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
125
Previous 125 -0.0%
Holding current value
$1,212
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$8.01 - $8.64 $1,025 - $1,105
-128 Reduced 50.59%
125 $1,000
Q4 2023

Jan 16, 2024

BUY
$7.78 - $8.62 $1,968 - $2,180
253 New
253 $2,000
Q1 2023

Apr 26, 2023

SELL
$7.57 - $8.37 $1,703 - $1,883
-225 Reduced 47.07%
253 $2,000
Q4 2022

Feb 21, 2023

BUY
$5.96 - $8.06 $1,341 - $1,813
225 Added 88.93%
478 $3,000
Q3 2022

Nov 22, 2022

BUY
$5.63 - $7.5 $1,424 - $1,897
253 New
253 $2,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.